Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty

ACK1

ACK1 (Activated Cdc42-associated Kinase 1), also known as TNK2, is a non-receptor tyrosine kinase activated by Cdc42, involved in regulating cell migration, proliferation, and survival. It influences signaling pathways like RAS and NF-kB, and plays a key role in cytoskeletal remodeling and cell adhesion. Overexpression of ACK1 is linked to cancer metastasis, making it a potential therapeutic target for cancer treatment.

Vemurafenib
T2382918504-65-1
Vemurafenib (RG7204) is a B-RAF inhibitor that inhibits RAFV600E and c-RAF-1 (IC50=31 48 nM) selectively and potently. Vemurafenib exhibits antitumor activity and is used for the treatment of BRAF V600E mutation-positive melanoma.
  • $50
In Stock
Size
QTY
TargetMol | Citations Cited
GNF-7
T3196839706-07-9
GNF-7 is Bcr-Abl WT and Bcr-Abl T315I inhibitor with IC50 of 133 nM and 61 nM, respectively.
  • $37
In Stock
Size
QTY
AIM-100
T5092873305-35-2
AIM-100 is a Ack1 inhibitor (IC50: 24 nM).
  • $42
In Stock
Size
QTY
TargetMol | Inhibitor Sale
AZ7550
T135641421373-99-0
AZ7550, an active metabolite of AZD9291, inhibits the activity of IGF1R (IC50: 1.6 μM).
  • $133
In Stock
Size
QTY
KRCA-0008
T26411472795-20-2
KRCA-0008 is an effective and specific ALK Ack1 inhibitor (IC50: 12 4 nM); displays drug-like properties without hERG liability.
  • $39
In Stock
Size
QTY